Cybin Inc. (NYSE American: CYBN) received a voluntary Form 4 from Eric H. L. So, the company's Executive Chair, who serves as both a director and officer. The filing reports that Mr. So acquired 95,000 Common Shares on September 1, 2026, at a price of $11.805 per share in an open-market purchase (transaction code "P"),...

This filing details a Form 4 submission for AvePoint, Inc. (AVPT) by Caci James, the Chief Financial Officer. On September 4, 2026, Mr. James engaged in several non-derivative transactions involving the company's common stock. Specifically, there were three transactions where a total of 5714 shares were disposed of (tr...

This filing details a transaction by Frank L. Muller, a director at California BanCorp (BCAL). On September 4, 2026, Muller acquired 450 shares of common stock at a price of $22.13 per share, increasing his post-transaction holdings to 2,377 shares. Following this transaction, Muller directly owns 37,933.43 shares of c...

David Meniane, CEO of CarParts.com, Inc., executed a series of stock purchases between September 4, 2026, and September 9, 2026. On September 4th, he acquired 21,154 shares of common stock at $9.11 per share, increasing his holdings to 241,029 shares. This was followed by the acquisition of 21,742 shares on September 8...

This filing details Form 4 transactions for Michael Huffaker, COO of CarParts.com, Inc. (PRTS). On September 4, 2026, Huffaker acquired 21,160 shares of common stock at $9.11 per share, increasing his post-transaction holdings to 81,262 shares. This was followed by another acquisition of 21,718 shares on September 8, 2...

This filing details a transaction by Carlson Megan, CAO and SVP, Finance of Butterfly Network, Inc. On September 4, 2026, Megan Carlson sold 13,804 shares of Class A Common Stock. The sale was executed under a "sell-to-cover" policy to satisfy tax withholding obligations related to the vesting of restricted stock units...

This filing details transactions by Brian Jay Carson, Chief Accounting Officer of CLEANSPARK, INC. (CLSK), on September 4th and 8th, 2026. The transactions primarily involve the disposition of Common Stock and Restricted Stock Units (RSUs). On September 4th, Mr. Carson disposed of 93,612 shares of Common Stock acquired...

This filing details a stock transaction by Steve Cashman, Chief Business Officer of Butterfly Network, Inc. On September 4, 2026, Mr. Cashman sold 140,112 shares of Class A Common Stock at a weighted average price of $7.302 per share. This sale was conducted under the company's "sell-to-cover" policy to satisfy tax wit...

This Form 4 filing discloses an open-market purchase of Castellum, Inc. (CTM) common stock by Andrew Merriman, the company's Chief Operating Officer. On September 9, 2026, Mr. Merriman acquired a total of 50,000 shares in two transactions: 40,000 shares at $0.6193 per share and 10,000 shares at $0.62 per share, for an ...

Century Therapeutics, Inc. (NASDAQ: IPSC) filed a Form 4 with the SEC reporting a transaction by Gregory Russotti, the company's Chief Technology and Manufacturing Officer. On September 8, 2026, Russotti sold 534 shares of Common Stock at a price of $2.05 per share, in a disposition (Code S) totaling approximately $1,0...

This SEC filing (Form 4) details a transaction by Brent Pfeiffenberger, President and CEO of Century Therapeutics, Inc. On September 4, 2026, Mr. Pfeiffenberger disposed of 463 shares of Common Stock at a price of $2.11 per share. This transaction was related to tax withholding obligations in connection with the vestin...

This SEC filing details transactions made by Chen Jeffrey, a director at ASE Technology Holding Co., Ltd., involving Ordinary Shares. On September 7, 2026, Chen Jeffrey acquired 300,000 Ordinary Shares, bringing his total to 2,683,000 shares. Subsequently, 600,000 shares were disposed of, reducing his holdings to 2,083...

Chen Sean Chihhsiang, President and COO of Ambiq Micro, Inc., reported several transactions on September 4, 2026. These transactions were conducted under a Rule 10b5-1 plan. Chihhsiang acquired 15,000 shares of Common Stock via the exercise of a stock option at a price of $8.12 per share. Concurrently, 12,874 shares we...

This filing reports a transaction by Chen Tien-Szu, identified as the General Manager of the Chung-Li Branch of ASE Inc. The transaction, dated September 7, 2026, involved the acquisition of 300,000 ordinary shares. The acquisition was made at a price of $0.0 per share. Following this transaction, the total number of o...

This filing details transactions made by Chuang Hao-Yuan, Chief Financial Officer of BELITE BIO, INC, on September 4th and 8th, 2026. A total of 35,135 American depositary shares were sold under a Rule 10b5-1 trading plan. The sales occurred at prices ranging from $180.16 to $198.05. Following these transactions, Mr. C...

Chung Chih-Hsiao, GM, ASE Japan & Wuxi Tongzhi, reported a transaction on September 7, 2026. The filing indicates the acquisition of 30,000 ordinary shares of ASE Technology Holding Co., Ltd. at a price of $0.0 per share. Following this transaction, the post-transaction shares owned by Chung Chih-Hsiao amount to 425,00...

This Form 4 filing details a transaction by Nault Casey M., EVP, GC & Secretary of Coeur Mining, Inc. On September 8, 2026, Nault Casey M. disposed of 10,000 shares of common stock with a par value of $0.01 per share. The weighted average sale price was $21.06 per share, with transactions occurring at prices ranging fr...

This filing details transactions by FIDELITY & GUARANTY LIFE INSURANCE CO, a ten percent owner of Crescent Capital BDC, Inc. (CCAP). On September 8, 2026, the company sold 126,436 shares of Common Stock at a volume-weighted average price of $10.3322, resulting in 3,819,361 shares held post-transaction. On September 9, ...

This Form 4 filing reports insider transactions by Jeffrey G. Korn, Chief Executive Officer of Crexendo, Inc. (NASDAQ: CXDO). On September 4, 2026, Mr. Korn vested restricted stock units into 11,110 shares of common stock across three separate RSU grants, with the company withholding 2,706 shares at $6.01 per share to ...

This Form 4 filing reports insider transactions by Vincent Ron, Chief Financial Officer of Crexendo, Inc. (CXDO). Between September 4 and September 5, 2026, Mr. Ron exercised vested Restricted Stock Units (RSUs), acquiring a total of 15,276 shares of Common Stock at an exercise price of $0. Concurrently, the company wi...

This filing details stock transactions by Gaylor Douglas Walter, Chief Operating Officer of Crexendo, Inc. On September 4, 2026, Mr. Walter acquired 5000 shares of Common Stock through Restricted Stock Units (RSUs) that vest over time, with 5000 underlying shares. He also acquired 277 shares via RSUs with 277 underlyin...

This filing details a transaction by Crone S Dustin, PRESIDENT & CEO of C&F FINANCE, involving the disposal of 900 shares of Common Stock in C&F Financial Corp on September 4, 2026. The transaction was executed at a price of $94.41 per share, resulting in a post-transaction ownership of 8378 shares. The filing was sign...

Nathaniel Glenn Crook, Chief Commercial Officer of Amplitude, Inc., reported a sale of 300,000 shares of Class A Common Stock on September 4, 2026. The sale was conducted under a 10b5-1 trading plan and the weighted average sale price was $12.9925 per share, with individual transactions ranging from $12.6150 to $13.510...

This Form 4 filing reports insider transactions by George Kurtz, President, CEO, and Director of CrowdStrike Holdings, Inc. (CRWD). Between September 4 and September 8, 2026, Kurtz sold a total of 20,000 shares of Class A common stock across 11 separate sale executions, all disposed of as sales ("S") at weighted averag...

John D. DiLullo, a director at D-Wave Quantum Inc. (QBTS), reported the sale of 1,100 shares of common stock on September 8, 2026. The sale was executed automatically under a Rule 10b5-1 trading plan adopted on June 15, 2025. The reported sale price of $18.0005 is a weighted average, with actual sale prices ranging fro...